Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Phase 2 Multi-center Open-label Basket Trial of Nab-sirolimus for Adult and Adolescent Patients With Malignant Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 or TSC2 Genes.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05103358
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-09-29T00:06:11.961604+00:00
Published At
2026-09-28T00:00:00+00:00
Record Updated At
2026-09-28
Results Posted At
2026-09-28
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Tumor", "Tumor, Solid", "Metastasis", "Metastatic Cancer", "Cancer", "Cancer Metastatic", "Tumors", "Neoplasms", "Neoplasm Metastasis", "Solid Tumor", "Advanced Solid Tumor", "Advanced Cancer", "Malignant Solid Tumor", "Malignant Solid Neoplasm", "Malignant Neoplasm", "Malignant Tumor", "TSC", "TSC1", "TSC2", "Metastatic Solid Tumor", "Metastatic Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-09-28"
protocolSection.identificationModule.nctId
"NCT05103358"
protocolSection.identificationModule.officialTitle
"A Phase 2 Multi-center Open-label Basket Trial of Nab-sirolimus for Adult and Adolescent Patients With Malignant Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 or TSC2 Genes."
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-09-28"

Study condition terms

  • Tumor (protocolSection.conditionsModule.conditions)
  • Tumor, Solid (protocolSection.conditionsModule.conditions)
  • Metastasis (protocolSection.conditionsModule.conditions)
  • Metastatic Cancer (protocolSection.conditionsModule.conditions)
  • Cancer (protocolSection.conditionsModule.conditions)
  • Cancer Metastatic (protocolSection.conditionsModule.conditions)
  • Tumors (protocolSection.conditionsModule.conditions)
  • Neoplasms (protocolSection.conditionsModule.conditions)
  • Neoplasm Metastasis (protocolSection.conditionsModule.conditions)
  • Solid Tumor (protocolSection.conditionsModule.conditions)
  • Advanced Solid Tumor (protocolSection.conditionsModule.conditions)
  • Advanced Cancer (protocolSection.conditionsModule.conditions)
  • Malignant Solid Tumor (protocolSection.conditionsModule.conditions)
  • Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
  • Malignant Neoplasm (protocolSection.conditionsModule.conditions)
  • Malignant Tumor (protocolSection.conditionsModule.conditions)
  • TSC (protocolSection.conditionsModule.conditions)
  • TSC1 (protocolSection.conditionsModule.conditions)
  • TSC2 (protocolSection.conditionsModule.conditions)
  • Metastatic Solid Tumor (protocolSection.conditionsModule.conditions)
  • Metastatic Neoplasm (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.